Drug intelligence / Profile preview

ficus carica leaf extract

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

**Ficus carica leaf extract** is a plant-derived extract obtained from the leaves of the common fig (*Ficus carica*). It contains a diverse array of **polyphenols, flavonoids, tannins, terpenoids, steroids, triterpenoids, alkaloids, and other secondary metabolites**[1][2][3]. The extract has been studied for its multifaceted biological activities, including: - **Antioxidant** (scavenges free radicals, high phenolic content) - **Anti-inflammatory** (inhibits cytokines like TNF-α, VEGF, PGE2; reduces WBC count in models) - **Antidiabetic** (inhibits enzymes like α-glucosidase and α-amylase, potentially beneficial in diabetes mellitus) - **Anticancer** (cytotoxicity in some cancer cell lines) - **Antibacterial** and **antimicrobial** - **Anticholinesterase** (AChE and BChE inhibition, potentially relevant for Alzheimer's disease) - **Hepatoprotective** - **Antiepileptic, anxiolytic, sedative-hypnotic, skeletal muscle relaxant** (via modulation of neurotransmitters and reduction of pro-inflammatory cytokines) Traditional and experimental uses include management of diabetes, inflammation-associated conditions (e.g., arthritis), infectious diseases, certain neurological disorders (epilepsy, anxiety), cancer, liver injury, and as a general antioxidant supplement[1][2][3]. The mechanism of action is **multi-target** and likely related to the combined effects of its bioactive phytochemicals. No single molecular target is responsible for all the effects; mechanisms reported include enzyme inhibition (AChE, BChE, α-amylase, α-glucosidase), cytokine modulation (e.g., TNF-α), and reduction of oxidative stress.

Other names
Ficus carica leaf extractfig leaf extractF. carica leaf extractfig leafFicus carica folium
02

Targets

Sucrase-IsomaltaseVEGFA (Vascular endothelial growth factor A)TNFA (Tumor necrosis factor alpha (soluble))ButyrylcholinesteraseAcetylcholinesteraseAMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on ficus carica leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ficus carica leaf extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call